Allergy Therapeutics
AGY.L
#7054
Rank
A$0.68 B
Marketcap
$0.14
Share price
1.45%
Change (1 day)
216.15%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -A$78.35 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$69.84 Million. In 2024 the company made an earning of -A$78.35 Million, an increase over its 2023 earnings that were of -A$83.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-A$78.35 Million-5.94%
2023-A$83.3 Million243.12%
2022-A$24.28 Million-403.33%
2021A$8 M-49.05%
2020A$15.7 M82.31%
2019A$8.61 M-159.83%
2018-A$14.41 Million255.37%
2017-A$4.06 Million-84.22%
2016-A$25.69 Million-1678.94%
2015A$1.62 M-44.28%
2014A$2.91 M129.45%
2013A$1.27 M-19.85%
2012A$1.58 M-127%
2011-A$5.88 Million2044.94%
2010-A$0.28 Million-99.08%
2009-A$29.78 Million-53.32%
2008-A$63.79 Million-21.76%
2007-A$81.53 Million351.81%
2006-A$18.05 Million230.51%
2005-A$5.46 Million-219.33%
2004A$4.57 M-58.79%
2003A$11.1 M-196.03%
2002-A$11.57 Million